This Award Notice opportunity from Florida was posted on June 30, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
A CHEMOTHERAPY-FREE TREATMENT REGIMEN FOR HER-2 POSITIVE BRE
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
Contract 25C18 is an award from the Florida Department of Health under the Florida Cancer Innovation Fund, granted to the H. Lee Moffitt Cancer Center and Research Institute, Inc. Led by Principal Investigator Hyo Han, the project focuses on developing a chemotherapy-free treatment regimen for HER-2 positive breast cancer by utilizing HER2-directed intratumoral dendritic cell immunotherapy in combination with Trastuzumab and Pertuzumab. The original contract amount is 1,429,728.00 dollars, with an initial start date of June 30, 2026. To ensure the successful completion of the research aims, the agreement has been modified through two amendments. Amendment A1 provided a no-cost extension of six months, extending the performance period to December 31, 2026. Subsequently, Amendment A2 updated the schedule of deliverables to align with this extended timeline. This initiative aligns with the broader goals of the Florida Cancer Innovation Fund to support emerging research trends and promising practices that serve as catalysts for cancer treatment innovation.
General Info
Contract Value
$1,429,728NAICS
Place of Performance
FL, USASet-Aside
Award Issued Date
Contract End Date
December 31, 2026Documents
4AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Ask CLEATUS
I've read this contract. Ask me anything.
Timeline
Organization & Contact Information
Full Description
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
